Reuters: World’s largest generic drugmaker earns 68 cents per diluted share in quarter; Teva’s debt falls to $25.9 billion at the end of 2020 from $26.9 billion a year earlier

Consortium of pharma and tech giants, including Merck, Teva, Amazon, will run new innovation lab to develop ecosystem, tap into new tech

Bloc accuses the Israeli pharma firm of colluding with a drugmaker it now owns to keep a generic version of modafinil off the market

Reuters: Drugmaker says it earned 58 cents per diluted share excluding one-time items in July to September, unchanged from the same period a year earlier

Justice Department says between 2013 and 2015 Teva and several co-conspirators agreed to 'fix prices, rig bids, and allocate customers for generic drugs

Sepehr Sarshar, 53, of Encinitas, California arrested on suspicion he provided friends and family details in 2015 about pending $3.2 billion buyout offer from Israel-based Teva

Accord reached with labor unions on firing half of the employees at Teva-Tech facility in Neot Hovav in the first quarter of 2022, as competition erodes profitability

Drugmaker accused of causing submission of false claims to Medicare by using kickbacks to boost sales of its drug Copaxone

Reuters: Israel-based Teva Pharmaceutical Industries, the world’s largest generic drugmaker, said revenue for the quarter fell 7% to $3.9 billion

Biosimilars are generic versions of biopharmaceutical drugs; Iceland's Alvotech will develop and supply the biosimilars and Teva will exclusively commercialize them in the US